|
1
|
Zhang B, Mo Z, Du W, Wang Y, Liu L and Wei
Y: Intensity-modulated radiation therapy versus 2D-RT or 3D-CRT for
the treatment of nasopharyngeal carcinoma: A systematic review and
meta-analysis. Oral Oncol. 51:1041–1046. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee AW, Ma BB, Ng WT and Chan AT:
Management of nasopharyngeal carcinoma: Current practice and future
perspective. J Clin Oncol. 33:3356–3364. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Szatkowska M and Krupa R: Regulation of
DNA damage response and homologous recombination repair by microRNA
in human cells exposed to ionizing radiation. Cancers (Basel).
12:18382020. View Article : Google Scholar
|
|
5
|
Jin H, Ko YS and Kim HJ: P2Y2R-mediated
inflammasome activation is involved in tumor progression in breast
cancer cells and in radiotherapy-resistant breast cancer. Int J
Oncol. 53:1953–1966. 2018.PubMed/NCBI
|
|
6
|
Cui C, Yang J, Li X, Liu D, Fu L and Wang
X: Functions and mechanisms of circular RNAs in cancer radiotherapy
and chemotherapy resistance. Mol Cancer. 19:582020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhou S, Bai ZL, Xia D, Zhao ZJ, Zhao R,
Wang YY and Zhe H: FTO regulates the chemo-radiotherapy resistance
of cervical squamous cell carcinoma (CSCC) by targeting β-catenin
through mRNA demethylation. Mol Carcinog. 57:590–597. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Artzi S, Kiezun A and Shomron N:
miRNAminer: A tool for homologous microRNA gene search. BMC
Bioinformatics. 9:392008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Macha MA, Seshacharyulu P, Krishn SR, Pai
P, Rachagani S, Jain M and Batra SK: MicroRNAs (miRNAs) as
biomarker(s) for prognosis and diagnosis of gastrointestinal (GI)
cancers. Curr Pharm Des. 20:5287–5297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tricoli JV and Jacobson JW: MicroRNA:
Potential for cancer detection, diagnosis, and prognosis. Cancer
Res. 67:4553–4555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gartel AL and Kandel ES: miRNAs: Little
known mediators of oncogenesis. Semin Cancer Biol. 18:103–110.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li LN, Xiao T, Yi HM, Zheng Z, Qu JQ,
Huang W, Ye X, Yi H, Lu SS, Li XH and Xiao ZQ: miR-125b increases
nasopharyngeal carcinoma radioresistance by targeting A20/NF-kappaB
signaling pathway. Mol Cancer Ther. 16:2094–2106. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu Z, Zhou S, Luo H, Ji M, Zheng J, Huang
F and Wang F: miRNA-17 promotes nasopharyngeal carcinoma
radioresistance by targeting PTEN/AKT. Int J Clin Exp Pathol.
12:229–240. 2019.PubMed/NCBI
|
|
14
|
Qu JQ, Yi HM, Ye X, Zhu JF, Yi H, Li LN,
Xiao T, Yuan L, Li JY, Wang YY, et al: miRNA-203 reduces
nasopharyngeal carcinoma radioresistance by targeting IL8/AKT
signaling. Mol Cancer Ther. 14:2653–2664. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xue J, Zhou A, Wu Y, Morris SA, Lin K,
Amin S, Verhaak R, Fuller G, Xie K, Heimberger AB and Huang S:
miR-182-5p Induced by STAT3 activation promotes glioma
tumorigenesis. Cancer Res. 76:4293–4304. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo J, Shi K, Yin SY, Tang RX, Chen WJ,
Huang LZ, Gan TQ, Cai ZW and Chen G: Clinical value of miR-182-5p
in lung squamous cell carcinoma: A study combining data from TCGA,
GEO, and RT-qPCR validation. World J Surg Oncol. 16:762018.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cao MQ, You AB, Zhu XD, Zhang W, Zhang YY,
Zhang SZ, Zhang KW, Cai H, Shi WK, Li XL, et al: miR-182-5p
promotes hepatocellular carcinoma progression by repressing FOXO3a.
J Hematol Oncol. 11:122018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spitschak A, Meier C, Kowtharapu B,
Engelmann D and Putzer BM: miR-182 promotes cancer invasion by
linking RET oncogene activated NF-κB to loss of the HES1/Notch1
regulatory circuit. Mol Cancer. 16:242017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Boyd JM, Malstrom S, Subramanian T,
Venkatesh LK, Schaeper U, Elangovan B, D'Sa-Eipper C and
Chinnadurai G: Adenovirus E1B 19 kDa and Bcl-2 proteins interact
with a common set of cellular proteins. Cell. 79:341–351. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Niu Y, Lin Z, Wan A, Chen H, Liang H, Sun
L, Wang Y, Li X, Xiong XF, Wei B, et al: RNA N6-methyladenosine
demethylase FTO promotes breast tumor progression through
inhibiting BNIP3. Mol Cancer. 18:462019. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shao Y, Liu Z, Liu J, Wang H, Huang L, Lin
T, Liu J, Wei Q, Zeng H, He G and Li X: Expression and epigenetic
regulatory mechanism of BNIP3 in clear cell renal cell carcinoma.
Int J Oncol. 54:348–360. 2019.PubMed/NCBI
|
|
22
|
Daido S, Kanzawa T, Yamamoto A, Takeuchi
H, Kondo Y and Kondo S: Pivotal role of the cell death factor BNIP3
in ceramide-induced autophagic cell death in malignant glioma
cells. Cancer Res. 64:4286–4293. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou WJ, Deng R, Feng GK and Zhu XF: A
G-quadruplex ligand SYUIQ-5 induces autophagy by inhibiting the
Akt-FOXO3a pathway in nasopharyngeal cancer cells. Ai Zheng.
28:1049–1053. 2009.(In Chinese). PubMed/NCBI
|
|
24
|
Xu WL, Wang SH, Sun WB, Gao J, Ding XM,
Kong J, Xu L and Ke S: Insufficient radiofrequency ablation-induced
autophagy contributes to the rapid progression of residual
hepatocellular carcinoma through the HIF-1α/BNIP3 signaling
pathway. BMB Rep. 52:277–282. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li XH, Qu JQ, Yi H, Zhang PF, Yi HM, Wan
XX, He QY, Ye X, Yuan L, Zhu JF, et al: Integrated analysis of
differential miRNA and mRNA expression profiles in human
radioresistant and radiosensitive nasopharyngeal carcinoma cells.
PLoS One. 9:e877672014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Feng X, Lv W, Wang S and He Q: miR495
enhances the efficacy of radiotherapy by targeting GRP78 to
regulate EMT in nasopharyngeal carcinoma cells. Oncol Rep.
40:1223–1232. 2018.PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Garcia DM, Baek D, Shin C, Bell GW,
Grimson A and Bartel DP: Weak seed-pairing stability and high
target-site abundance decrease the proficiency of lsy-6 and other
microRNAs. Nat Struct Mol Biol. 18:1139–1146. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Agarwal V, Bell GW, Nam JW and Bartel DP:
Predicting effective microRNA target sites in mammalian mRNAs.
Elife. 4:e050052015. View Article : Google Scholar
|
|
30
|
Farhan M, Wang H, Gaur U, Little PJ, Xu J
and Zheng W: FOXO signaling pathways as therapeutic targets in
cancer. Int J Biol Sci. 13:815–827. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang Y, Gan B, Liu D and Paik JH: FoxO
family members in cancer. Cancer Biol Ther. 12:253–259. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Shuai M and Huang L: High expression of
hsa_circRNA_001387 in nasopharyngeal carcinoma and the effect on
efficacy of radiotherapy. Onco Targets Ther. 13:3965–3973. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kam MK, Leung SF, Zee B, Chau RM, Suen JJ,
Mo F, Lai M, Ho R, Cheung KY, Yu BK, et al: Prospective randomized
study of intensity-modulated radiotherapy on salivary gland
function in early-stage nasopharyngeal carcinoma patients. J Clin
Oncol. 25:4873–4879. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Peng G, Wang T, Yang KY, Zhang S, Zhang T,
Li Q, Han J and Wu G: A prospective, randomized study comparing
outcomes and toxicities of intensity-modulated radiotherapy vs.
conventional two-dimensional radiotherapy for the treatment of
nasopharyngeal carcinoma. Radiother Oncol. 104:286–293. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Co J, Mejia MB and Dizon JM: Evidence on
effectiveness of intensity-modulated radiotherapy versus
2-dimensional radiotherapy in the treatment of nasopharyngeal
carcinoma: Meta-analysis and a systematic review of the literature.
Head Neck. 38 (Suppl 1):E2130–E2142. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mao YP, Tang LL, Chen L, Sun Y, Qi ZY,
Zhou GQ, Liu LZ, Li L, Lin AH and Ma J: Prognostic factors and
failure patterns in non-metastatic nasopharyngeal carcinoma after
intensity-modulated radiotherapy. Chin J Cancer. 35:1032016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang W, Shi G, Yong Z, Li J, Qiu J, Cao
Y, Zhao Y and Yuan L: Downregulation of RKIP promotes
radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1
axis via downregulating miR-450b-5p. Cell Death Dis. 11:5042020.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu W, Chen X, Yu S, Wang R, Zhao R and Du
C: MicroRNA-222 promotes tumor growth and confers radioresistance
in nasopharyngeal carcinoma by targeting PTEN. Mol Med Rep.
17:1305–1310. 2018.PubMed/NCBI
|
|
39
|
Qu C, Liang Z, Huang J, Zhao R, Su C, Wang
S, Wang X, Zhang R, Lee MH and Yang H: miR-205 determines the
radioresistance of human nasopharyngeal carcinoma by directly
targeting PTEN. Cell Cycle. 11:785–796. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li G, Wang Y, Liu Y, Su Z, Liu C, Ren S,
Deng T, Huang D, Tian Y and Qiu Y: miR-185-3p regulates
nasopharyngeal carcinoma radioresistance by targeting WNT2B in
vitro. Cancer Sci. 105:1560–1568. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang Y, Tan D, Xiao J, Li Q, Zhang X and
Luo Z: miR-150 contributes to the radioresistance in nasopharyngeal
carcinoma cells by targeting glycogen synthase kinase-3β. J Cancer
Res Ther. 14:111–118. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guo Y, Zhai J, Zhang J, Ni C and Zhou H:
Improved radiotherapy sensitivity of nasopharyngeal carcinoma cells
by miR-29-3p targeting COL1A1 3′-UTR. Med Sci Monit. 25:3161–3169.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qu JQ, Yi HM, Ye X, Li LN, Zhu JF, Xiao T,
Yuan L, Li JY, Wang YY, Feng J, et al: miR-23a sensitizes
nasopharyngeal carcinoma to irradiation by targeting IL-8/Stat3
pathway. Oncotarget. 6:28341–28356. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao YS, Yang WC, Xin HW, Han JX and Ma
SG: miR-182-5p knockdown targeting PTEN inhibits cell proliferation
and invasion of breast cancer cells. Yonsei Med J. 60:148–157.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xu X, Ayub B, Liu Z, Serna VA, Qiang W,
Liu Y, Hernando E, Zabludoff S, Kurita T, Kong B and Wei JJ:
Anti-miR182 reduces ovarian cancer burden, invasion, and
metastasis: An in vivo study in orthotopic xenografts of nude mice.
Mol Cancer Ther. 13:1729–1739. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Segura MF, Hanniford D, Menendez S, Reavie
L, Zou X, Alvarez-Diaz S, Zakrzewski J, Blochin E, Rose A,
Bogunovic D, et al: Aberrant miR-182 expression promotes melanoma
metastasis by repressing FOXO3 and microphthalmia-associated
transcription factor. Proc Natl Acad Sci USA. 106:1814–1819. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen X, Gong J, Zeng H, Chen N, Huang R,
Huang Y, Nie L, Xu M, Xia J, Zhao F, et al: MicroRNA145 targets
BNIP3 and suppresses prostate cancer progression. Cancer Res.
70:2728–2738. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Burton TR, Eisenstat DD and Gibson SB:
BNIP3 (Bcl-2 19 kDa interacting protein) acts as transcriptional
repressor of apoptosis-inducing factor expression preventing cell
death in human malignant gliomas. J Neurosci. 29:4189–4199. 2009.
View Article : Google Scholar : PubMed/NCBI
|
